MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13018-026-07013-w

Медицинская библиотека · Journal of orthopaedic surgery and research · 2026

Intra-articular platelet-rich plasma demonstrates superior clinical and serum biomarker outcomes compared with corticosteroids and NSAIDs in late-stage knee osteoarthritis: a randomised controlled trial.

Lacko Marek, Awad Omar, Matúška Martin, Strážik Michal, Barej Juraj, Filip Vladimír, Slovinská Lucia, Matejová Jana, Harvanová Denisa

СтатьяРандомизированное исследованиеСравнительное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

To assess the efficacy of two autologous platelet-rich plasma injections (PRP) in treating late-stage knee osteoarthritis and their effects on joint pain, stiffness and function as well as serum biomarkers reflecting inflammation, and cartilage turnover.

METHODS

Ninety patients (aged 40-80 years) with symptomatic KL 3-4 KOA on arthroplasty waiting lists were randomized to PRP (two injections one week apart) and CS (a single injection of betamethasone), or NSAID (aceclofenac tablets) as the control groups. Primary outcomes included VAS pain scores, WOMAC scores, opioid use, and serum biomarkers (COMP, MMP-3, CGRP, CCL2, VEGF, IL-6, IL-18, TNF-α, CX3CL1, sTREM2, sRAGE, TGF-β1, BDNF) were measured at baseline, 3 months, and 6 months.

RESULTS

Eighty-two patients completed the 6-month follow-up. Baseline characteristics (VAS, WOMAC) were comparable among the groups. PRP treatment resulted in significant and sustained reductions in VAS pain scores at 3 and 6 months compared with those at baseline (p < 0.001) and in both control groups (3 months: p < 0.001 vs. CS and NSAID; 6 months: p = 0.004 vs. CS; p = 0.002 vs. NSAID). WOMAC total and subscale scores (pain, stiffness, function) improved significantly only in the PRP group at both follow-up points (all p ≤ 0.03), with significant intergroup differences favoring PRP. Opioid consumption was significantly lower in the PRP group than in the CS and NSAID groups at 3 months (p = 0.002 and p = 0.025, respectively) and than in the CS group at 6 months (p = 0.006). At 3 months, PRP significantly reduced levels of proinflammatory and cartilage degradation biomarkers (COMP, MMP-3, IL-6, IL-18, TNF-α) and CGRP compared with controls, while increasing levels of anti-inflammatory markers (sTREM2, sRAGE, TGF-β1). Several effects were maintained at 6 months, including continued reductions in COMP, IL-6, and IL-18 levels compared with the CS group and in IL-6 and TNF-α levels compared with the NSAIDs group. No significant changes were observed in MCP-1, VEGF, CX3CL1, BDNF, or β-NGF. Adverse events were mild and transient in the PRP group.

CONCLUSION

Two PRP injections demonstrated greater 6-month clinical and biomarker improvements compared to CS and NSAIDs in late-stage KOA, supporting PRP as a safe bridge therapy prior to arthroplasty.

Для цитирования: Lacko Marek, Awad Omar, Matúška Martin, Strážik Michal, Barej Juraj, Filip Vladimír, Slovinská Lucia, Matejová Jana, Harvanová Denisa. Intra-articular platelet-rich plasma demonstrates superior clinical and serum biomarker outcomes compared with corticosteroids and NSAIDs in late-stage knee osteoarthritis: a randomised controlled trial.. Journal of orthopaedic surgery and research. 2026. DOI: 10.1186/s13018-026-07013-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.